La cadena de opciones muestra datos clave de las opciones de acciones de Avenue Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Avenue Therapeutics..

Avenue Therapeutics (OTC:ATXI) Bolsa, Cadena de Opciones

Avenue Therapeutics

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. Its current product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's Disease), intravenous tramadol (IV tramadol) for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Las acciones de Harrow subieron un 23,1% en el premercado. Descubre qué otras compañías están ganando y perdiendo antes de la apertura.

Las acciones de Harrow (HROW) se disparan un 23%; aquí están 20 acciones que se mueven en el premercado

AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc.

Avenue Therapeutics Inc

Avenue Therapeutics Ends License Agreement with AnnJi

AVENUE THERAPEUTICS, INC. Quarterly Report (Form10)

Fortress Biotech, Inc. Quarterly Report (Form10)

Nasdaq Stock Market LLC (Form25-NSE) (0001354457-25-000696)

Earnings

Avenue Therapeutics Q2 EPS $0.11 Up From $(6.43) YoY, Sales $1.404M

Avenue Therapeutics Reports Positive Earnings Amid Challenges

CKPT

DERM

FBIO

FBIOP

MBIO

Maxim Group

Aegis Capital

Comments

Avenue Therapeutics

Avenue Therapeutics (ATXI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL